For example, mucinous tumors displayed a more active immune response compared to the other low-grade carcinomas, with relatively higher levels of CD8 cytotoxic T cells and immune activation marker VISTA, while lower in immune suppressive markers (IDO1, FOXP3, CTLA4). This evidence concerns the gene IDO1 and mucinous neoplasm.